China has gradually developed into the world's largest supplier of raw materials for plant extracts. From the perspective of export markets, China's plant extract export markets are concentrated in the United States, Europe and Asia, with the United States, Japan, India, Hong Kong, China, Malaysia, Indonesia, South Korea, Spain, Germany and France being the top ten markets for China's plant extract exports. China has not yet developed a directory of plant extracts as raw materials for food and health food, the regulatory approach is unclear, and only the Chinese medicine extracts included in the pharmacopoeia have corresponding standards. It is understood that the Ministry of Agriculture and Rural Development will study the development of regulations related to plant extracts feed additives, and put forward the technical requirements for feature mapping, plant extracts will make a substantial breakthrough in the raw materials of farming inputs. It is understood that because there is no uniform national standards, some are implemented in accordance with the standards of food, some are implemented in accordance with the standards of drugs, some are implemented in accordance with the technical requirements approved during the registration review, and each health food in the registration review of raw materials used in the extract standards and processes are different, which caused the extract production enterprises to organize production in accordance with multiple processes, which seriously affects the production efficiency, while the frequent replacement of processes and replacement systems make it difficult to control the quality of the product, resulting in a great waste of production resources, but also to the compliance of the production enterprises caused great distress. Plant extracts have been developed in China for only about 30 years and are an emerging industry. The scattered and small size of the industry has led to a lack of industrial agglomeration, and as a raw material industry, the imperfect regulations and standards make the end product development and market expansion lack of momentum. At the same time, China is the world's largest producer of plant extracts, with abundant plant resources and leading international extraction technology and equipment level. The challenges and opportunities of the plant extract industry coexist. Relevant experts said that the lack of standards has led to the lagging standards of food raw materials, the plant extract industry should strengthen the basic research, food raw materials should establish rules and develop industry standards for grading and classification; standardization is the basis of the development of the plant extract industry, without standardization it is impossible to achieve scale and industrialization, solving the problem of standardization of raw materials will allow plant extracts as health food raw materials have the basis of regulations; plant extracts should establish a dir...

According to customs data, in September 2021, China's exports of lysine and lysine salts and esters were 78,500 tons, up 21.3% YoY and up 24.8% YoY. From January to September 2021, China's exports of lysine with lysine salts and esters were 569,000 tons, down 2.75% YoY, and the export value was US$695 million, up 32% YoY. From January to September 2021, China's exports of lysine to some countries in Europe and the United States declined, and the top ten countries for its exports were the Netherlands, Germany, Thailand, Vietnam, the Russian Federation, Denmark, Poland, Lithuania, Canada, the United States and Japan. Among them, the highest export volume to the Netherlands was 68,300 tons, down 3.79% year-on-year, followed by Germany with 34,400 tons, down 10.44% year-on-year. The third is Thailand, exports of 29,500 tons, down 7.37% year-on-year. 2021 January-September China's exports of lysine to the United States 17,000 tons, down 50.85% year-on-year.

On the morning of May 21, the "Communiqué of the Seventh National Census of Hefei" was released. Statistics show that the permanent population of Hefei is 9,369,900, which is an increase of 1.913 million or 25.7% compared with the 7.457 million in the sixth national census in 2010. Ranked sixth in the Yangtze River Delta urban agglomeration. Census data shows that Hefei has a permanent population of 5.12 million, and it has entered the ranks of megacities in accordance with the national urban scale classification standards. Among the counties (cities), districts and development zones, Baohe has the largest population with a population of 1.217 million, followed by Shushan District with a population of 1.047 million, making it two districts in Hefei with a population of over one million.

Dear customers, In order to improve the user experience, Keynovo Biotech.com will suspend updates and push services from May 15th. In the next two to three weeks, Keynovo Biotech.com will renovate its website. The new Keynovo Biotech.com will add more AI designs to product display, inquiry management and contact. At the same time, Keynovo Biotech.com will add new solutions for medicine, cosmetics, food, and nutritional supplements. In order to provide buyers with one-stop service. The new Keynovo Biotech.com will be officially launched in the first week of June, so stay tuned!

August 25, 2020. After 1 month of preparation, Keynovo Biotech obtained the hazardous chemical business license. Within this month, Keynovo Biotech passed the hazardous chemical management examination held by the Emergency Management Bureau and successfully passed the field review. The acquisition of the hazardous chemicals business license means that Keynovo Biotech can smoothly export hazardous chemicals such as eucalyptus oil and camphor in the future. Congratulations to the Keynovo Biotech team and also thanks to Ms. Debe for her hard work!